Sharita Harding LMSW

Recommended Articles

• Stem Cell Therapy Can Reduce Inflammation in Cystic Fibrosis

  Cystic fibrosis can cause numerous lung infections that will lead to lung damage and a weaker respiratory system. Scientists have therefore taken to researching different rehabilitation methods on repairing lung damage. There have been a number of recent breakthroughs in lung rehabilitation, but one...

• What Causes ADHD?

  Attention deficit hyperactivity disorder (ADHD) is a neurological/behavioral disorder that affects a person's ability to control one's behavior. The real cause of attention deficit hyperactivity disorder (ADHD) is unknown, although numerous factors are thought to be responsible. GeneticsPeople...

• The Best Anti-Aging Tips

  Experts in the field of anti-aging believe that it is never too late to start the anti-aging essentials. Although it is not very obvious, the skin actually starts aging by mid-20's. The major factors that really make a difference for the killing looks are genes, daily skin routine, and sun...

• Young Girl Gets ‘Game Changer’ in Fight Against Cystic Fibrosis

  At just one month old, Raelyn Copeland from Slidell, Louisiana was diagnosed with cystic fibrosis, a hereditary disorder characterized by the accumulation of mucus in the lungs that makes it difficult to breathe properly. Her mother, Angela Spencer, immediately began to advocate, campaign, and hold...

• 5 Treatments for Excessive Sweating

  What is excessive sweating?Excessive sweating is also known as hyperhidrosis. Abnormal and excessive sweating is not necessarily related to a rise in body temperature or intensive exercises. In this condition, sweating is so excessive that it tends to soak the clothes of an individual. At times,...

• FDA Approves Baricitinib for Adults with Active Rheumatoid Arthritis

  On June 1st of 2018, the US Food and Drug Administration (FDA) approved Olumiant (Baricitinib) for the treatment of adults with moderate to severe rheumatoid arthritis (RA) who have had an inadequate response or intolerance to one or more TNF inhibitor therapies. “We are pleased to provide RA...